Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEPHG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,822
Award facts
- Contract value 100% obligated
- $13,822.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a $13,822.24 firm fixed-price delivery order from the Defense Logistics Agency on January 7, 2026. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with a $499.999 billion ceiling value awarded under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative on November 13, 2025. The PPV-G GEN V represents a strategic $30.3 billion acquisition vehicle designed to establish multiple regional prime vendor contractors to supply the full range of pharmaceutical products needed by Department of Defense military healthcare facilities worldwide. No set-aside designation was used for this delivery order award.
The delivery order authorizes DMS Pharmaceutical Group to supply pharmaceutical products and medical consumables in support of federal military healthcare operations. As part of the broader PPV-G GEN V program, DMS Pharmaceutical Group is positioned to deliver comprehensive pharmaceutical solutions including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals to meet the recurring medical supply needs of DoD healthcare operations. The contract structure with a completion date of January 8, 2026, reflects the immediate delivery requirements, while the underlying IDC extends through December 31, 2036, with three optional 30-month renewal periods to ensure sustained pharmaceutical supply chain support for military medical facilities.
Quick answers
Who was awarded contract SPE2DU26FEPHG?
SPE2DU26FEPHG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DU26FEPHG worth?
The government has obligated $13,822 on SPE2DU26FEPHG.
Is contract SPE2DU26FEPHG an order under another contract?
Yes. SPE2DU26FEPHG is a delivery order under SPE2DU25D9418, an indefinite delivery contract.
Was contract SPE2DU26FEPHG competed?
The extent of competition for SPE2DU26FEPHG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award